文献速递肿瘤 PET/CT

原发肿瘤PSMA强度是根治性前列腺切除术后生化复发无生存的独立预后生物标志物

Primary tumour PSMA intensity is an independent prognostic biomarker for biochemical recurrence-free survival following radical prostatectomy.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2022-03-17

该回顾性队列研究纳入848例根治性前列腺切除术前完成多参数MRI、经会阴前列腺穿刺活检及68Ga-PSMA PET/CT的男性,分析原发肿瘤PSMA强度(SUVmax)与术后生化复发无生存(BRFS)的关系。中位随访41个月,219例发生事件,3年BRFS为79%、5年BRFS为70%;PSMA强度升高与BRFS较差相关(Log rank p<0.001),校正术前参数后每5单位SUVmax增加的HR=1.15,校正术后参数后HR=1.10。作者结论认为PSMA强度是BRFS的独立预后因素。

要点

  • 848例根治性前列腺切除术前完成mpMRI、经会阴穿刺及68Ga-PSMA PET/CT的男性纳入回顾性队列。
  • 中位随访41个月,219例事件,3年BRFS为79%、5年BRFS为70%。
  • PSMA强度升高与BRFS较差相关,校正术前HR每5单位SUVmax=1.15、校正术后HR=1.10。

核心结论

  • 在大型患者系列中,结果证实PSMA强度是BRFS的新型独立预后因素。

研究设计与样本

  • 回顾性队列研究,纳入848例根治性前列腺切除术前完成多参数MRI、经会阴前列腺穿刺活检及68Ga-PSMA PET/CT的男性。

主要发现

  • 中位随访41个月,219例事件发生,估计3年BRFS为79%、5年BRFS为70%。
  • PSMA强度升高与总体BRFS较差相关(Log rank p<0.001),在Gleason评分亚组内亦相关(Log rank p<0.03)。
  • 校正术前参数后,PSMA强度与更短至生化复发时间显著相关(每5单位SUVmax增加HR=1.15)。
  • 校正术后参数后,PSMA强度与更短至生化复发时间显著相关(每5单位SUVmax增加HR=1.10)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The prognostic value of PSMA intensity on PSMA PET/CT due to underlying biology and subsequent clinical implications is an emerging topic of interest. We sought to investigate whether primary tumour PSMA PET intensity contributes to pre- and post-operative prediction of oncological outcomes following radical prostatectomy. METHODS: We performed a retrospective cohort study of 848 men who underwent all of multiparametric MRI (mpMRI), transperineal prostate biopsy, and 68 Ga-PSMA PET/CT prior to radical prostatectomy. PSMA intensity, quantified as maximum standard uptake value (SUVmax), and other clinical variables were considered relative to post-operative biochemical recurrence-free survival (BRFS) using Cox regression and Kaplan-Meier analysis. RESULTS: After a median follow-up of 41 months, 219 events occurred; the estimated 3-year BRFS was 79% and the 5-year BRFS was 70%. Increasing PSMA intensity was associated with less favourable BRFS overall (Log rank p < 0.001), and within subgroups of Gleason score category (Log rank p < 0.03). PSMA intensity was significantly associated with shorter time to biochemical recurrence, after adjusting for pre-operative (HR per 5-unit SUVmax increase = 1.15) and post-operative (HR per 5-unit SUVmax increase = 1.10) parameters. CONCLUSION: These results in a large series of patients confirm PSMA intensity to be a novel, independent prognostic factor for BRFS.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Roberts MJ, Morton A, Papa N, et al. Primary tumour PSMA intensity is an independent prognostic biomarker for biochemical recurrence-free survival following radical prostatectomy. Eur J Nucl Med Mol Imaging. 2022. PMID: 35298693. doi:10.1007/s00259-022-05756-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。